SCHEMBL19377387

SCHEMBL19377387

CCc1ccc(Cl)c(C(=O)NC(=O)Nc2ccc(S(=O)(=O)Cc3ccc4c(c3)CNC4)cc2)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GHSR Q92847 1/20 0.45
▸ USP28 Q96RU2 2/20 0.43
▸ MLNR O43193 3/20 0.42
▸ PCTP Q9UKL6 5/20 0.41
▸ STARD10 Q9Y365 2/20 0.39
▸ STARD7 Q9NQZ5 1/20 0.39
▸ DRD2 P14416 1/20 0.39
▸ DRD3 P35462 1/20 0.39
▸ HTR6 P50406 1/20 0.39
▸ MEN1 O00255 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ RORC P51449 1/20 0.37
▸ HSP90AA1 P07900 1/20 0.37
▸ OPRD1 P41143 1/20 0.37
▸ OPRK1 P41145 1/20 0.37
▸ TLR9 Q9NR96 1/20 0.37
▸ PYGL P06737 1/20 0.37
▸ NPC1 O15118 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ KCNA5 P22460 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19377430 0.89 GHSR (0.46) GHSRUSP28MLNRPCTPSTARD10
SCHEMBL19377110 0.88 DRD2 (0.54) GHSRUSP28MLNRPCTPSTARD10
SCHEMBL19377297 0.84 GHSR (0.47) GHSRMEN1KMT2ATLR9NPC1
SCHEMBL19377260 0.84 PCTP (0.46) GHSRUSP28PCTPSTARD10STARD7
SCHEMBL19384137 0.82 MLNR (0.39) USP28MLNRDRD2DRD3HTR6
SCHEMBL19377302 0.81 HTR6 (0.57) GHSRUSP28MLNRPCTPSTARD10
SCHEMBL24800494 0.80 RORC (0.52) DRD2DRD3HTR6MEN1KMT2A
SCHEMBL19377005 0.80 GHSR (0.53) GHSRPCTPSTARD10STARD7
SCHEMBL19377434 0.80 MMP2 (0.46) GHSRMLNRDRD2DRD3HTR6
SCHEMBL19377184 0.77 NAMPT (0.47) GHSRMLNRDRD2DRD3HTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3390355-B1 BENZENESULFONYL-ASYMMETRIC UREAS AND MEDICAL USES THEREOF HELSINN HEALTHCARE SA (CH) 2022-12-28 — — EP claimed
US-20170275301-A1 Benzenesulfonyl-Asymmetric Ureas and Medical Uses Thereof HELSINN HEALTHCARE SA (CH) 2017-09-28 — — US claimed
EP-3390355-B1 BENZENESULFONYL-ASYMMETRIC UREAS AND MEDICAL USES THEREOF HELSINN HEALTHCARE SA (CH) 2022-12-28 — — EP disclosed
EP-3390355-B1 BENZENESULFONYL-ASYMMETRIC UREAS AND MEDICAL USES THEREOF HELSINN HEALTHCARE SA (CH) 2022-12-28 — — EP disclosed
US-20170275301-A1 Benzenesulfonyl-Asymmetric Ureas and Medical Uses Thereof HELSINN HEALTHCARE SA (CH) 2017-09-28 — — US disclosed
US-20170275301-A1 Benzenesulfonyl-Asymmetric Ureas and Medical Uses Thereof HELSINN HEALTHCARE SA (CH) 2017-09-28 — — US disclosed
US-20170275301-A1 Benzenesulfonyl-Asymmetric Ureas and Medical Uses Thereof HELSINN HEALTHCARE SA (CH) 2017-09-28 — — US disclosed
WO-2017162390-A1 BENZENESULFONYL-ASYMMETRIC UREAS AND MEDICAL USES THEREOF HELSINN HEALTHCARE SA (CH) 2017-09-28 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170275301-A1 Benzenesulfonyl-Asymmetric Ureas and Medical Uses Thereof UTS2R, GHSR, GRPR GHSR 2/4885USP28 142/4885MLNR 24/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback